News
Sensorion Will Present Two Posters At The American Society Of Cell And Gene Therapy (ASGCT) 26th Annual Meeting
Regulatory News:
Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in gene therapies in the ear, is pleased to announce its participation in
Poxel Announces Upcoming Participation at the JMP Securities Life Science Conference
Regulatory News:
POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic
Transgene provides business update and Q1 2023 financial position
Regulatory News:
Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today provides a business update, including
MYHOTELMATCH: Strong Financial Results of MYHOTELMATCH Subsidiaries confirmed
GEVELOT S.A.: Weekly report of share buyback May 10, 2023
BILENDI: Q1 2023 revenues: €13.8 million up +3%, +4.4% at constant exchange rates
Kaufman & Broad SA: RESULT OF VOTES OF THE ORDINARY AND EXTRAORDINARY SHAREHOLDERS' MEETING OF MAY 4, 2023
Transgene - First Patient Dosed in Phase I Trial Evaluating TG6050, a Novel IL-12-Armed Oncolytic Virus Administered Intravenously, in Non-Small Cell Lung Cancer
Regulatory News:
Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, announced that the first patient has been
Verimatrix präsentiert Streamkeeper, VCAS und XTD-Lösungen auf der CABSAT und ANGA COM
Verimatrix, (Euronext Paris: VMX) (Paris:VMX), der führende Anbieter von Sicherheitstechnologien für die moderne vernetzte Welt, gab heute bekannt, dass das Unternehmen seine bahnbrechenden Video-
Verimatrix To Highlight Streamkeeper, VCAS and XTD Solutions at CABSAT and ANGA COM
Regulatory News:
Verimatrix, (Euronext Paris: VMX) (Paris:VMX), the leader in powering the modern connected world with people-centered security, today announced it’s scheduled to showcase its
Transgene’s Combined General Meeting of May 5, 2023
Regulatory News:
The Combined Ordinary and Extraordinary General Meeting of Transgene’s (Paris:TNG) shareholders was held today (May 5, 2023) at 9:00 a.m. at the Company’s headquarters (400
Kaufman & Broad SA: DESCRIPTION OF THE SHARE REPURCHASE PROGRAM 2023
Transgene Announces New Leadership Structure to Accelerate the Development of its Innovative Immunotherapy Portfolio
Regulatory News:
Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancer, announced that the Board has appointed Dr Alessandro
EQS-News: Abivax publishes Universal Registration Document 2023 “Document d’Enregistrement Universel”
Kaufman & Broad SA: DIVIDEND PAYMENT IN RESPECT OF THE FINANCIAL YEAR ENDED NOVEMBER 30, 2022
GEVELOT S.A.: Weekly report of share buyback May 3, 2023
Verimatrix Wins 2023 NAB Show Product of the Year Award
Regulatory News:
Verimatrix, (Euronext Paris: VMX) (Paris:VMX), the leader in powering the modern connected world with people-centered security, today announced that Verimatrix Streamkeeper was
Eutelsat Joins The GSOA, Driving the Satellite Communications Ecosystem of the Future
Regulatory News:
Eutelsat Communications (Euronext Paris: ETL) (Paris:ETL) announces that it has become a full member of the Brussels-based Global Satellite Operators Association (GSOA), the
Verimatrix To Demo New App Security Technology at 2023 RSA Conference
Regulatory News:
Verimatrix, (Euronext Paris: VMX) (Paris:VMX), the leader in powering the modern connected world with people-centered security, today announced it will demo its latest
Verimatrix präsentiert neue Sicherheitstechnologie-App auf der RSA Conference 2023
Verimatrix, der führende Anbieter von Sicherheitslösungen für die moderne vernetzte Welt, kündigte heute an, dass er auf seine neueste Verimatrix XTD UX und Design auf der diesjährigen RSA
Sensorion to Host a Symposium during ISIET’s International Symposium on Inner Ear Therapeutics on April 30, 2023
Regulatory News:
Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in gene therapies in the ear, is pleased to announce it will host a
Median Technologies to Host Two Webcasts and Provide a Company Update on May 3, 2023
Regulatory News:
Median Technologies (ALMDT:PA) announced today that Fredrik Brag, CEO and Founder of Median Technologies, will provide a company update on May 3rd, 2023 during two webcasts:
Teleperformance Announces Proposed Acquisition of Majorel
Regulatory News:
Teleperformance (Paris:TEP), a global leader in digital business services, today announced its proposed voluntary cash and share offer for all shares in Majorel (the "Shares")
Verimatrix XTD Wins 2023 Global Infosec Award
Regulatory News:
Verimatrix, (Euronext Paris: VMX) (Paris:VMX), the leader in powering the modern connected world with people-centered security, today announced that Verimatrix XTD (Extended